In 2024, documented allocations of opioid settlement funds included about $615 million for treatment, $279 million for overdose-reversal medications and related training, and $227 million for housing-related programs for people with substance use disorders.
December 31, 2024
high
temporal
Breakdown of major spending categories from documented 2024 opioid settlement expenditures.
In 2024, trackable opioid settlement spending included about $615 million for treatment, $279 million for overdose-reversal medications and related training, $227 million for housing-related programs for people with substance use disorders, more than $237 million (about 9% of trackable spending) for prevention efforts, and roughly 20% of settlement funds were untrackable through public records.
December 31, 2024
high
temporal
Breakdown of categories and amounts from tracked 2024 opioid settlement spending, based on compiled public records.